AACR Blog Features Timely Post for Brain Cancer Awareness Month
PHILADELPHIA – In recognition of May as Brain Cancer Awareness Month, the American Association for Cancer Research (AACR) recently published a post on the AACR’s official blog, Cancer Research Catalyst, about new treatment options for brain tumors:
In this post, author Andrew Matthius summarizes recent clinical advances in treating gliomas and glioblastomas (grade 4 gliomas) that were discussed at the AACR Annual Meeting 2024, including one new drug, vorasidenib, that could be approved later this summer.
Journalists are encouraged to use this blog post in their reporting. Please cite the American Association for Cancer Research and link to the post.
This post is part of Cancer Research Catalyst’s continuing mission to accelerate the growth and spread of knowledge about cancer while providing helpful and interesting information to AACR members and the public.